We aim to determine population-based EVT rate, treatment delay, and clinical outcomes by geographical areas in Catalonia, Spain.
G
iven the clinical benefit of endovascular treatment (EVT) in acute ischemic stroke (AIS) patients with large vessel occlusion, critical organizational changes to acute stroke care models are needed to deliver the new standard of care in an equitable way covering the whole population. 1 Timely access to EVT may be unequal for AIS patients according to their geographical location. 2 For patients living in remote areas, transfer from local centers to a Comprehensive Stroke Center (CSC) is time-consuming and may cause a loss of effectiveness of EVT.
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Stroke Centers and 5 CSC, the later located in the metropolitan area of Barcelona. In 2013, the stroke network was expanded by adding 12 new TeleStroke Centers ( Figure 1 ). Patients with suspected acute stroke attended by the Emergency Medical Services are transferred to the nearest Stroke Center, regardless of hospital type and patient's characteristics. Patients with suspected large vessel occlusion admitted to a Primary Stroke Center or a TeleStroke Centers are secondarily transferred to a CSC after initiating infusion of intravenous recombinant tissue-type plasminogen activator (IV r-tPA). This observational study is based on data available in the SONIIA registry, a prospective government-mandated registry of AIS patients treated with reperfusion therapies, either IV r-tPA and EVT. Further details of the registry have been published elsewhere. 4 For this study, we used data from consecutive patients treated with EVT since 2013 when the new Stroke Network including 21 referring hospitals was established. The SONIIA register satisfies all legal requirements mandated by the local law of protection of personal data.
For this analysis, the Catalan territory was divided into 3 areas based on their distance to the nearest CSC. Area A corresponds to the metropolitan area of Barcelona (2.9 million inhabitants) and includes health areas primarily covered by CSCs, which are reachable in <30 minutes. Area B (2.7 million inhabitants) includes areas primarily covered by local stroke centers (Primary Stroke Centers or TeleStroke Centers) located <1 hour away from a CSC (maximum distance 80 km). Finally, area C includes the provinces (1.9 million inhabitants) and is covered by local stroke centers located >1 hour away from a CSC (from 80 to 200 km; Figure 1 ).
Outcome Measures and Statistical Analysis
The main outcome variable was the population rate of EVT (number of EVT×100 000 inhabitants/year). Secondary outcomes were time from symptom onset to IV r-tPA, time to CSC arrival, and time to groin puncture. Successful arterial recanalization was considered as modified Thrombolysis in Cerebral Infarction (mTICI) perfusion score 2b-3. Good clinical outcome at 3 months was considered as a modified Rankin scale score ≤2. Symptomatic hemorrhagic transformation was evaluated according to European Cooperative Acute Stroke Study II (ECASS II) criteria. Analysis was performed by year-periods to determine changes on EVT rate or delays throughout the years. Baseline characteristics and outcomes between groups were compared using Chi-square test for categorical variables and nonparametric Kruskal-Wallis test for continuous variables.
Results
From 2013 to 2015, a total of 965 patients received EVT in Catalonia: 662 (68%) in area A, 191 (20%) in area B, and 112 (12%) in area C. There were no significant differences between the 3 groups in baseline characteristics (age, sex, vascular risk factors, and stroke severity), except a lower proportion of primary EVT (patients with contraindications for IV r-tPA) in B and C drip-and-ship areas than in the A mothership area (Table) .
The EVT rate was 3-fold higher for group A compared with group B and C for all the periods analyzed. EVT rate increased 2-folds in all the areas. Currently, the EVT year rate is 10.5 per 100 000 inhabitants for group A, 3.7 for group B, and 2.7 for group C (Figure 2) .
Time from symptom onset to groin puncture was 82 minutes longer for group B and 120 minutes longer for group C compared with group A. A longer time from symptom onset to CSC arrival was also observed in groups B and C, suggesting that delays were mostly because of interhospital transfers rather than in-hospital delays at the CSC (Table) . For patients in group C, helicopter transportation was used in 34% of patients. This modality was associated with a shorter time from symptom onset to groin puncture (ground 367 [318-425] min versus air 320 [270-375] min; P=0.02).
There were no differences in symptomatic hemorrhagic transformation, postprocedure complete recanalization, functional outcome, and mortality rates at 3 months by the geographical areas (Table) .
Discussion
In our region, patients living in areas not directly covered by a CSC are 3× less likely to receive EVT and are treated within longer times than patients living in areas primarily covered by CSCs.
The 2015 population EVT rate in areas of Catalonia directly covered by a CSC is high and probably close to the maximum estimated, but it drops significantly in referring areas. Zaidat et al reported a projected rate between 8.6 and 31 EVT/100 000 inhabitants/year, 6 close to the 10/100 000 found in the metropolitan area of Barcelona. It is worth noting that after REVASCAT trial, the overall rate of EVT increased, but differences between areas were still marked. Clinical characteristics of patients from CSC and referring areas were similar, suggesting absence of selection bias explaining differences in the rate of EVT. Our data show a huge inequity between geographical areas, an effect that is 
Pérez de la Ossa et al Population Endovascular Therapy Rate in Catalonia 1383
probably generalizable to many other countries. In a study of the 2011 US population, only 0.5% of AIS patients underwent EVT, and 56% of them were 60-minute drive away to an endovascular-capable hospital. 7 Health systems need organizational changes to assure that patients who are candidates for EVT can have access to timely adequate care. In Catalonia, a decentralized stroke care model was progressively developed from 2006 to 2013 to ensure rapid access to IV r-tPA, which currently reaches 15% of AIS patients throughout the region. 8 However, with the advent of EVT, such a decentralized model can be disadvantageous because time from onset to CSC arrival and to groin puncture are around 2 hours longer for transferred patients.
The main strength of our study is that data of patients treated with reperfusion therapies are based on a high-quality, prospective, mandatory, and monitored regional registry. As a limitation, we have no information about patients with large vessel occlusion who did not receive EVT, so we cannot deep into detail about the particular causes of the lower rate of EVT in patients from referring centers.
In summary, this study demonstrates that high rates of EVT is feasible in well-organized areas covered directly by CSC, but accessibility to EVT from remote areas is hampered by lower rate and longer time to treatment. Based on these results, strategies to shorten interhospital transfer times, alternatives to favor mothership models, and certification of new CSC should be considered. 
